The present work focused on elucidating the levels of LINC01857 in BC tissues and cells and exploring the possible mechanisms of LINC01857 in functional activities of BC cell metastasis and angiogenesis, which will imply the potential of LINC01857 to be a novel potential treatment target in treating BC. This evidence concerns the gene LINC01857 and breast cancer.